View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Melanoma/Skin Cancer News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 11, 2023
2 min read
Save

Melanoma staging system inaccurately reflects recurrence, mortality risk

Melanoma staging system inaccurately reflects recurrence, mortality risk

Findings from a nationwide, population-based cohort study revealed that the current staging system used for melanoma does not represent accurate recurrence and mortality.

SPONSORED CONTENT
September 07, 2023
1 min read
Save

RNA-sequencing, spatial transcriptomics trace ‘aggressive behavior’ in SCC

RNA-sequencing, spatial transcriptomics trace ‘aggressive behavior’ in SCC

Single-cell RNA-sequencing and spatial transcriptomics may be able to identify tumor-specific keratinocyte subpopulations that mark aggressive squamous cell carcinoma in at-risk patients, according to a review.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
August 29, 2023
3 min read
Save

Chronic immune-related adverse events common after anti-PD-1 therapy for melanoma

Chronic immune-related adverse events common after anti-PD-1 therapy for melanoma

Chronic immune-associated adverse events appeared common after treatment with adjuvant anti-PD-1 therapy among patients with melanoma, according to study results published in JAMA Network Open.

SPONSORED CONTENT
August 24, 2023
2 min read
Save

Weight-based dosing strategy could sharply reduce spending on U.S. cancer drugs

Weight-based dosing strategy could sharply reduce spending on U.S. cancer drugs

Combining weight-based dosing and single-use vial sharing within individual Veterans Affairs hospitals could reduce immune checkpoint inhibitor spending by millions annually, according to study results published in Health Affairs.

SPONSORED CONTENT
August 24, 2023
2 min read
Save

Immunotherapy combination improves PFS in pretreated melanoma

Immunotherapy combination improves PFS in pretreated melanoma

The combination of ipilimumab and nivolumab extended PFS compared with ipilimumab alone as second-line therapy for patients with advanced melanoma resistant to PD-1 inhibitors, according to study results published in Nature Medicine.

SPONSORED CONTENT
August 23, 2023
2 min read
Save

Survival in Merkel cell carcinoma may improve with Mohs vs. wide local excision

Survival in Merkel cell carcinoma may improve with Mohs vs. wide local excision

Patients with Merkel cell carcinoma may have better survival outcomes when treated with Mohs micrographic surgery compared with wide local excision, according to a study.

SPONSORED CONTENT
August 17, 2023
2 min read
Save

High cardiorespiratory fitness may lower risk for certain cancers up to 40%

High cardiorespiratory fitness may lower risk for certain cancers up to 40%

High cardiorespiratory fitness was linked to reductions in head and neck, colon, esophagus, stomach, pancreas, liver, rectum, kidney and lung cancers among men, according to a study published in the British Journal of Sports Medicine.

SPONSORED CONTENT
August 14, 2023
1 min read
Save

Novel nonsurgical immunotherapy treatment shows promise in basal cell carcinoma

Novel nonsurgical immunotherapy treatment shows promise in basal cell carcinoma

Verrica Pharmaceuticals Inc. has reported lesion clearance data from part one of an ongoing phase 2 study of VP-315 for the treatment of basal cell carcinoma, according to a press release from Verrica’s licensing partner, Lytix Biopharma.

SPONSORED CONTENT
August 10, 2023
2 min read
Save

Neoadjuvant T-VEC confers durable survival benefits for resectable melanoma

Neoadjuvant T-VEC confers durable survival benefits for resectable melanoma

Neoadjuvant talimogene laherparepvec conferred durable benefits for patients with advanced resectable melanoma, according to study results published in JAMA Oncology.

SPONSORED CONTENT
August 08, 2023
3 min read
Save

Black, Hispanic individuals experience poorer outcomes after second cancer diagnosis

Black, Hispanic individuals experience poorer outcomes after second cancer diagnosis

An analysis of individuals diagnosed with second primary cancers showed Black individuals exhibited considerably higher risks for cancer-related and cardiovascular-related deaths than white individuals.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails